Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials
Authors
Keywords
-
Journal
PSYCHOPHARMACOLOGY
Volume 237, Issue 8, Pages 2485-2497
Publisher
Springer Science and Business Media LLC
Online
2020-06-04
DOI
10.1007/s00213-020-05548-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
- (2019) Michael C. Mithoefer et al. PSYCHOPHARMACOLOGY
- Comparative Efficacy and Acceptability of Pharmacological, Psychotherapeutic, and Combination Treatments in Adults With Posttraumatic Stress Disorder
- (2019) Jasmin Merz et al. JAMA Psychiatry
- Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline
- (2019) Allison A. Feduccia et al. Frontiers in Psychiatry
- MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?
- (2018) Allison A. Feduccia et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial
- (2018) Marcela Ot’alora G et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy
- (2017) Mark T Wagner et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Comparative efficacy and acceptability of pharmacological treatments for post-traumatic stress disorder in adults: a network meta-analysis
- (2017) Andrea Cipriani et al. PSYCHOLOGICAL MEDICINE
- Posttraumatic stress disorder in the World Mental Health Surveys
- (2017) K. C. Koenen et al. PSYCHOLOGICAL MEDICINE
- Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA)
- (2017) Matthew B. Young et al. PSYCHOPHARMACOLOGY
- Progress and promise for the MDMA drug development program
- (2017) Allison A. Feduccia et al. PSYCHOPHARMACOLOGY
- Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects
- (2017) Patrick C. Dolder et al. PSYCHOPHARMACOLOGY
- Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials
- (2017) Neeltje M Batelaan et al. BMJ-British Medical Journal
- Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials
- (2017) Neeltje M Batelaan et al. BMJ-British Medical Journal
- PSYCHOTHERAPY VERSUS PHARMACOTHERAPY FOR POSTTRAUMATIC STRESS DISORDER: SYSTEMIC REVIEW AND META-ANALYSES TO DETERMINE FIRST-LINE TREATMENTS
- (2016) Daniel J. Lee et al. DEPRESSION AND ANXIETY
- Effects of 3,4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting
- (2016) Matthew J Baggott et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?
- (2016) Anya K Bershad et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- (2016) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Connectivity
- (2015) Robin L. Carhart-Harris et al. BIOLOGICAL PSYCHIATRY
- Psychotherapy for Military-Related PTSD
- (2015) Maria M. Steenkamp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Intimate insight: MDMA changes how people talk about significant others
- (2015) Matthew J Baggott et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals
- (2015) Philip Kamilar-Britt et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- 3,4-Methylenedioxymethamphetamine facilitates fear extinction learning
- (2015) M B Young et al. Translational Psychiatry
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
- (2014) Peter Gasser et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
- Differential effects of MDMA and methylphenidate on social cognition
- (2014) Yasmin Schmid et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A Window into the Intoxicated Mind? Speech as an Index of Psychoactive Drug Effects
- (2014) Gillinder Bedi et al. NEUROPSYCHOPHARMACOLOGY
- MDMA effects consistent across laboratories
- (2014) Matthew G. Kirkpatrick et al. PSYCHOPHARMACOLOGY
- The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories
- (2013) R. L. Carhart-Harris et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Effectiveness of National Implementation of Prolonged Exposure Therapy in Veterans Affairs Care
- (2013) Afsoon Eftekhari et al. JAMA Psychiatry
- Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study
- (2012) Michael C Mithoefer et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)
- (2012) Peter Oehen et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults
- (2011) Kelly Posner et al. AMERICAN JOURNAL OF PSYCHIATRY
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
- (2010) Charles S. Grob et al. ARCHIVES OF GENERAL PSYCHIATRY
- Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others
- (2010) Gillinder Bedi et al. BIOLOGICAL PSYCHIATRY
- The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study
- (2010) Michael C Mithoefer et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effects of MDMA on sociability and neural response to social threat and social reward
- (2009) Gillinder Bedi et al. PSYCHOPHARMACOLOGY
- Treatment of post-traumatic stress disorder with eye movement desensitization and reprocessing: Outcome is stable in 35-month follow-up
- (2008) Göran Högberg et al. PSYCHIATRY RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now